Sensitive and reliable proarrhythmiain vivoanimal models for predicting drug‐induced torsades de pointes in patients with remodelled hearts
Author:
- 1 August 2008
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 154 (7) , 1528-1537
Abstract
As an increasing number of non‐cardiac drugs have been reported to cause QT interval prolongation and torsades de pointes (TdP), we extensively studied the utility of atrioventricular (AV) block animals as a model to predict their torsadogenic action in human. The present review highlights suchin vivoproarrhythmia models. In the case of the canine model, test substances were administered p.o. at conscious state >4 weeks after the induction of AV block, with subsequent Holter ECG monitoring to evaluate drug effects. Control AV block dogs (no pharmacological treatment) survive for several years without TdP attack. For pharmacologically treated dogs, drugs were identified as high, low or no risk. High‐risk drugs induced TdP at 1–3 times the therapeutic dose. Low‐risk drugs did not induce TdP at this dose range, but induced it at higher doses. No‐risk drugs never induced TdP at any dose tested. Electrophysiological, anatomical histological and biochemical adaptations against persistent bradycardia‐induced chronic heart failure were observed in AV block dogs. Recently, we have developed another highly sensitive proarrhythmia model using a chronic AV block cynomolgus monkey, which possesses essentially the same pathophysiological adaptations and drug responses as those demonstrated in the canine model. As a common remodelling process leading to a diminished repolarization reserve may present in patients who experience drug‐induced TdP and in the AV block animals, thein vivoproarrhythmia models described in this review may be useful for predicting the risk of pharmacologically induced TdP in humans.British Journal of Pharmacology(2008)154, 1528–1537; doi:fn1; published online 16 June 2008Keywords
This publication has 88 references indexed in Scilit:
- Ventricular Tachycardia Storm After Initiation of Biventricular Pacing: Incidence, Clinical Characteristics, Management, and OutcomeJournal of Cardiovascular Electrophysiology, 2008
- No proarrhythmic properties of the antibiotics Moxifloxacin or Azithromycin in anaesthetized dogs with chronic‐AV blockBritish Journal of Pharmacology, 2006
- A Rabbit Langendorff Heart Proarrhythmia Model: Predictive Value for Clinical Identification of Torsades de PointesBritish Journal of Pharmacology, 2006
- Reduction of repolarization reserve by halothane anaesthesia sensitizes the guinea-pig heart for drug-induced QT interval prolongationBritish Journal of Pharmacology, 2005
- Famotidine and long QT syndromeThe American Journal of Cardiology, 2004
- Proarrhythmic potential of halofantrine, terfenadine and clofilium in a modified in vivo model of torsade de pointesBritish Journal of Pharmacology, 2002
- In Vivo Canine Model Comparison of Cardiohemodynamic and Electrophysiological Effects of a New Antipsychotic Drug Aripiprazole (OPC-14597) to HaloperidolToxicology and Applied Pharmacology, 2001
- Proarrhythmia of Azimilide and Other Class III Antiarrhythmic Agents in the Adrenergically Stimulated RabbitProceedings of the Society for Experimental Biology and Medicine, 2000
- Effects of the Antihypoxic and Neuroprotective Drug, Lubeluzole, on Repolarization Phase of Canine Heart Assessed by Monophasic Action Potential RecordingToxicology and Applied Pharmacology, 1996
- QTU-Prolongation and Torsades de Pointes Induced by Putative Class III Antiarrhythmic Agents in the RabbitJournal of Cardiovascular Pharmacology, 1990